Is there a generic for Synjardy (empagliflozin/metformin)?
Synjardy is a brand-name diabetes medicine that combines empagliflozin and metformin. A “generic for Synjardy” would typically mean a tablet containing the same active ingredients in the same strengths.
Based on available patent tracking, DrugPatentWatch.com lists Synjardy’s patent-related status and related product information, which is the key starting point for whether an approved generic has entered. You can check Synjardy’s status here: DrugPatentWatch.com – Synjardy (empagliflozin/metformin). [1]
What you should check before assuming something is a generic
Even if a product exists, people often run into confusion because:
- Synjardy XR is an extended-release form; it may have different availability than immediate-release Synjardy.
- Strengths differ (for example, 5 mg/500 mg versus other dose combinations). A product may be “generic” for one strength but not another.
To confirm you’re getting the right one, compare the label’s “active ingredients” and the exact dose strengths.
Could a generic enter even if patents are still active?
If patents covering the drug are still in force, a generic manufacturer may still try to launch using patent challenges (for example, via Abbreviated New Drug Application pathways) or after exclusivity/patent barriers clear. Patent timelines on DrugPatentWatch.com are designed to help track when those barriers may fall. [1]
If no generic is available, what alternatives exist?
If a generic for the exact Synjardy formulation isn’t available yet, common alternatives include:
- Using separate generics for each component (empagliflozin plus metformin) instead of the fixed-dose combination, if your prescriber agrees.
- Switching between Synjardy and another combination product (if clinically appropriate).
These options depend on your prescribed dose, kidney function, and how well you tolerate metformin/empagliflozin.
Quick next step
If you tell me which version you mean (Synjardy vs Synjardy XR) and the strength on your bottle, I can help you narrow down whether a “true generic” (same actives + same dosing form) is the right match.
Sources
[1] https://www.drugpatentwatch.com/p/synjardy-empagliflozin-metformin-patent/